Neurologique Foundation, Inc.
1 clinical trials · Sponsor
◉ Watch Neurologique Foundation, Inc.
| Record | Firm | Date |
|---|---|---|
| Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone (NCT00947895) | Neurologique Foundation, Inc. | 2009-10-01 |
Track Neurologique Foundation, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.